Immunic, Inc. - Common Stock (NQ:IMUX)
Price and Volume
Detailed Quote| Volume | 3,618,695 |
| Open | 1.080 |
| Bid (Size) | 1.160 (2,500) |
| Ask (Size) | 1.180 (900) |
| Prev. Close | 1.070 |
| Today's Range | 1.060 - 1.200 |
| 52wk Range | 0.5062 - 1.350 |
| Shares Outstanding | 26,249,439 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
What's going on in today's pre-market session ↗
February 13, 2026
Why Did IMUX Stock Surge 33% Pre-Market Today? ↗
February 13, 2026
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
November 18, 2025
Immunic (IMUX) Q2 Loss Widens 25% ↗
August 07, 2025
Immunic, Inc. Announces Proposed Public Offering ↗
July 07, 2025
Wednesday's session: top gainers and losers ↗
April 30, 2025
Wednesday's session: gap up and gap down stocks ↗
April 30, 2025
Frequently Asked Questions
Is Immunic, Inc. - Common Stock publicly traded?
Yes, Immunic, Inc. - Common Stock is publicly traded.
What exchange does Immunic, Inc. - Common Stock trade on?
Immunic, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Immunic, Inc. - Common Stock?
The ticker symbol for Immunic, Inc. - Common Stock is IMUX on the Nasdaq Stock Market
What is the current price of Immunic, Inc. - Common Stock?
The current price of Immunic, Inc. - Common Stock is 1.170
When was Immunic, Inc. - Common Stock last traded?
The last trade of Immunic, Inc. - Common Stock was at 03/04/26 04:00 PM ET
What is the market capitalization of Immunic, Inc. - Common Stock?
The market capitalization of Immunic, Inc. - Common Stock is 30.71M
How many shares of Immunic, Inc. - Common Stock are outstanding?
Immunic, Inc. - Common Stock has 31M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
